Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
Rebecca J. Garten,1,*C. Todd Davis,1,*Colin A. Russell,2,3Bo Shu,1Stephen Lindstrom,1Amanda Balish,1Wendy M. Sessions,1Xiyan Xu,1Eugene Skepner,2Varough Deyde,1Margaret Okomo-Adhiambo,1Larisa Gubareva,1John Barnes,1Catherine B. Smith,1Shannon L. Emery,1Michael J. Hillman,1Pierre Rivailler,1James Smagala,1Miranda de Graaf,2,4David F. Burke,2Ron A. M. Fouchier,4Claudia Pappas,1Celia M. Alpuche-Aranda,5Hugo López-Gatell,5Hiram Olivera,5Irma López,5Christopher A. Myers,6Dennis Faix,6Patrick J. Blair,6Cindy Yu,7Kimberly M. Keene,8P. David Dotson, Jr.,9David Boxrud,10Anthony R. Sambol,11Syed H. Abid,12Kirsten St. George,13Tammy Bannerman,14Amanda L. Moore,15David J. Stringer,16Patricia Blevins,17Gail J. Demmler-Harrison,18Michele Ginsberg,19Paula Kriner,20Steve Waterman,21Sandra Smole,22Hugo F. Guevara,23Edward A. Belongia,24Patricia A. Clark,25Sara T. Beatrice,26Ruben Donis,1Jacqueline Katz,1Lyn Finelli,1Carolyn B. Bridges,1Michael Shaw,1Daniel B. Jernigan,1Timothy M. Uyeki,1Derek J. Smith,2,3,4,Alexander I. Klimov,1Nancy J. Cox1,
Since its identification in April 2009, an A(H1N1) virus containinga unique combination of gene segments from both North Americanand Eurasian swine lineages has continued to circulate in humans.The lack of similarity between the 2009 A(H1N1) virus and itsnearest relatives indicates that its gene segments have beencirculating undetected for an extended period. Its low geneticdiversity suggests that the introduction into humans was a singleevent or multiple events of similar viruses. Molecular markerspredictive of adaptation to humans are not currently presentin 2009 A(H1N1) viruses, suggesting that previously unrecognizedmolecular determinants could be responsible for the transmissionamong humans. Antigenically the viruses are homogeneous andsimilar to North American swine A(H1N1) viruses but distinctfrom seasonal human A(H1N1).
1 WHO Collaborating Center for Influenza, Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA. 2 Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK. 3 Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA. 4 Department of Virology, Erasmus Medical Center, 3000 CA Rotterdam, NL. 5 Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE) Prolongación de Carpio, México, 11340 Mexico DF. 6 Naval Health Research Center, San Diego, CA 92152, USA. 7 Arizona State Public Health Laboratory, Phoeniz, AZ 85007, USA. 8 Colorado Department of Public Health and Environment, Denver, CO 80230, USA. 9 Indiana State Department of Health Laboratories, Indianapolis, IN 46202, USA. 10 Public Health Laboratory, Minnesota Department of Health, St. Paul, MN 55164, USA. 11 Nebraska Public Health Laboratory, Omaha, NE 68198, USA. 12 Westchester County Department of Laboratories & Research Public Health Laboratories, Valhalla, NY 10595,USA. 13 Wadsworth Center, New York State Department of Health, Slingerlands, NY 12159, USA. 14 Ohio Department of Health Laboratory, Reynoldsburg, OH 43068, Reynoldsburg, OH 43068, USA. 15 South Carolina Department of Health and Environmental Control, Columbia, SC 29223, USA. 16 Dallas County Health and Human Services, Dallas, TX 75207, USA. 17 San Antonio Metro Health District, Brooks City–Base, TX 78235, USA. 18 Diagnostic Virology Laboratory, Texas Childrens Hospital, Houston, TX 77030, USA. 19 San Diego Public Health Laboratory, San Diego, CA 92186, USA. 20 Imperial County Public Health Department, El Centro, CA 92243, USA. 21 CDC Border Infectious Disease Surveillance Project, Atlanta, GA 30333, USA. 22 William A. Hinton State Laboratory Institute, Massachusetts Department of Public Health, Jamaica Plain, MA 02130, USA. 23 California Department of Public Health, Viral and Rickettsial Disease Laboratory, Richmond, CA 94804, USA. 24 Marshfield Clinic Research Foundation, Marshfield, WI 54449, USA. 25 Michigan Department of Community Health, Lansing, MI 48906, USA. 26 Public Health Laboratory, NYC Department of Health and Mental Hygiene, New York, NY 10016, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: dsmith{at}zoo.cam.ac.uk (D.J.S.); njc1{at}cdc.gov (N.J.C.)
The editors suggest the following Related Resources on Science sites:
In Science Magazine
NEWS OF THE WEEK
Jon Cohen (29 May 2009) Science324 (5931), 1127.
[DOI: 10.1126/science.324_1127] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Swine-origin influenza virus A(H1N1)v: lessons learnt from the early phase of the epidemic.
G. Rezza (2009)
Eur J Public Health
19, 572-573
|Full Text »|PDF »
Observations on Past Influenza Pandemics.
J. M. Barry (2009)
Disaster Med Public Health Preparedness
3, S95-S99
|Full Text »|PDF »
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus.
K. Hancock, V. Veguilla, X. Lu, W. Zhong, E. N. Butler, H. Sun, F. Liu, L. Dong, J. R. DeVos, P. M. Gargiullo, et al. (2009)
N. Engl. J. Med.
361, 1945-1952
|Abstract »|Full Text »|PDF »
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009.
S. Jain, L. Kamimoto, A. M. Bramley, A. M. Schmitz, S. R. Benoit, J. Louie, D. E. Sugerman, J. K. Druckenmiller, K. A. Ritger, R. Chugh, et al. (2009)
N. Engl. J. Med.
361, 1935-1944
|Abstract »|Full Text »|PDF »
The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus.
Y. Yang, J. D. Sugimoto, M. E. Halloran, N. E. Basta, D. L. Chao, L. Matrajt, G. Potter, E. Kenah, and I. M. Longini Jr. (2009)
Science
326, 729-733
|Abstract »|Full Text »|PDF »
Glycans on influenza hemagglutinin affect receptor binding and immune response.
Systematic Review: Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza.
N. Khazeni, D. M. Bravata, J.-E. C. Holty, T. M. Uyeki, C. D. Stave, and M. K. Gould (2009)
Ann Intern Med
151, 464-473
|Abstract »|Full Text »|PDF »
Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City.
L. Garcia-Garcia, J. L. Valdespino-Gomez, E. Lazcano-Ponce, A. Jimenez-Corona, A. Higuera-Iglesias, P. Cruz-Hervert, B. Cano-Arellano, A. Garcia-Anaya, E. Ferreira-Guerrero, R. Baez-Saldana, et al. (2009)
BMJ
339, b3928
|Abstract »|Full Text »|PDF »
Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine -- Preliminary Report.
M. E. Greenberg, M. H. Lai, G. F. Hartel, C. H. Wichems, C. Gittleson, J. Bennet, G. Dawson, W. Hu, C. Leggio, D. Washington, et al. (2009)
N. Engl. J. Med.
|Abstract »|Full Text »|PDF »
Darwinian selection for sites of Asn-linked glycosylation in phylogenetically disparate eukaryotes and viruses.
J. Cui, T. Smith, P. W. Robbins, and J. Samuelson (2009)
PNAS
106, 13421-13426
|Abstract »|Full Text »|PDF »
Detection of Novel (Swine Origin) H1N1 Influenza A Virus by Quantitative Real-Time Reverse Transcription-PCR.
R. Wang, Z.-M. Sheng, and J. K. Taubenberger (2009)
J. Clin. Microbiol.
47, 2675-2677
|Full Text »|PDF »